Literature DB >> 27564726

Validation of International Classification of Diseases Codes for the Epidemiologic Study of Dermatomyositis.

Michael C Kwa1, Kaveh Ardalan2, Anne E Laumann1, Beatrice Nardone1, Dennis P West1, Jonathan I Silverberg1.   

Abstract

OBJECTIVE: To assess the validity of using International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) code 710.3 to identify adult patients with dermatomyositis in outpatient and inpatient settings.
METHODS: Electronic medical records of adult patients with ICD-9 code 710.3 between January 2001 and November 2014 (n = 511) were examined. Physician diagnosis, clinical findings, and diagnostic testing results were recorded. A dermatomyositis rating scale was assigned based on classic cutaneous findings and at least 2 additional clinical and diagnostic findings from the Bohan criteria. Sensitivity and positive predictive values (PPVs) were determined. Sensitivity analyses were performed to evaluate the accuracy of multiple ICD-9 codes in the outpatient setting, as well as primary and secondary inpatient codes.
RESULTS: The sensitivity and PPV for multiple 710.3 ICD-9 codes in the outpatient setting were 0.89 and 0.35, respectively. The PPV for primary and secondary 710.3 inpatient codes was 0.95 and as high as 0.8. However, the sensitivity of ICD-9 code 710.3 was poor in the inpatient setting (primary 0.23 and secondary 0.26). The most common reason for failure to meet appropriate dermatomyositis criteria was miscoding as diabetes mellitus (32%), followed by diagnosis at an outside institution (19%), dermatomyositis as a rule-out diagnosis (10%), cutaneous dermatomyositis (8%), and juvenile dermatomyositis (6%).
CONCLUSION: One or more occurrences of ICD-9 code 710.3 is insufficient to support the diagnosis of dermatomyositis in the outpatient setting. However, ICD-9 710.3 codes appear to be valid in the inpatient setting.
© 2016, American College of Rheumatology.

Entities:  

Mesh:

Year:  2017        PMID: 27564726     DOI: 10.1002/acr.23010

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  4 in total

1.  Preterm birth phenotypes in women with autoimmune rheumatic diseases: a population-based cohort study.

Authors:  K D Kolstad; J A Mayo; L Chung; Y Chaichian; V M Kelly; M Druzin; D K Stevenson; G M Shaw; J F Simard
Journal:  BJOG       Date:  2019-10-31       Impact factor: 6.531

2.  Pregnancy outcomes in adult patients with dermatomyositis and polymyositis.

Authors:  Kathleen D Kolstad; David Fiorentino; Shufeng Li; Eliza F Chakravarty; Lorinda Chung
Journal:  Semin Arthritis Rheum       Date:  2017-11-20       Impact factor: 5.532

3.  Assessment of the Accuracy of Using ICD-10 Codes to Identify Systemic Sclerosis.

Authors:  Sébastien De Almeida Chaves; Hélène Derumeaux; Phuong Do Minh; Maryse Lapeyre-Mestre; Guillaume Moulis; Grégory Pugnet
Journal:  Clin Epidemiol       Date:  2020-12-08       Impact factor: 4.790

4.  Inpatient mortality in transition-aged youth with rheumatic disease: an analysis of the National Inpatient Sample.

Authors:  Paul T Jensen; Keumseok Koh; Rebecca E Cash; Stacy P Ardoin; Ayaz Hyder
Journal:  Pediatr Rheumatol Online J       Date:  2020-03-30       Impact factor: 3.054

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.